NASDAQ · Medical - Pharmaceuticals

Bio Green Med Solution, Inc. (BGMS) Stock

$0.85 +3.41% NASDAQ: BGMS Healthcare

Valuation

MetricValue
Price$0.85
Market Cap$4.69M
P/E Ratio-0.24
P/B Ratio0.68
P/S Ratio2.59
EPS (TTM)$0.00
52-Week High$6.70
52-Week Low$0.57
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-31.60%
ROA-28.02%
ROCE-38.23%
Gross Margin18.36%
Operating Margin-2.38%
Net Margin-118.27%
Debt/Equity0.00
Current Ratio6.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-22.0M$-28.0M$-25.0M$-12.0M$-8.0M
Net Profit$-18.0M$-21.0M$-23.0M$-11.0M$-3.0M
EPS$-7704.00$-6840.00$-6420.00$-501.60$-6.45
Op Margin——-6060.2%-27916.3%-1128.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$43.0M$28.0M$9.0M$4.0M$8.0M
Total Liabilities$5.0M$8.0M$8.0M$6.0M$1.0M
Cash$37.0M$18.0M$3.0M$3.0M$4.0M
Borrowings$0$0$0$0$0

Latest News

Top Premarket Gainers MT Newswires · Jun 5, 2026 Bio Green Med Solution Enters Business Combination Agreement to Acquire Future NRG MT Newswires · Jun 4, 2026 BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. GlobeNewswire · Jun 4, 2026 BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE GlobeNewswire · May 14, 2026 Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments GlobeNewswire · Apr 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-21.0M$-16.0M$-8.0M$-5.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$2.0M$-1.0M
Net Cash Flow$3.0M$-18.0M$-15.0M$0$0
Free Cash Flow$-19.0M$-21.0M$-16.0M$-8.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.38
FCF Yield-22.80%
Quick Ratio7.22
Interest Coverage0.00
Return 1Y-92.66%
Return 3Y-99.91%
Return 5Y-99.99%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BBLGBone Biologics Corp $0.47 -0.43% -0.26 $845628 0.00%
BFRGBullfrog AI Holdings, Inc. $0.65 -6.70% -1.26 $11.98M 0.00%
BNBX $0.16 +0.00% 0.00 $210492 0.00%
CNSPCNS Pharmaceuticals, Inc. $5.35 +0.00% -0.23 $7.82M 0.00%
MOVECorvex, Inc. $9.84 +0.31% -0.93 $7.47M 0.00%

About Bio Green Med Solution, Inc.

Bio Green Med Solution, Inc. is led by CEO Sing Ee Wong, employs 12 people, headquartered in US, publicly traded since 2025.

Bio Green Med Solution, Inc. (BGMS) stock trades at $0.85 with a market capitalization of $4.69M. The stock is valued at a price-to-earnings (P/E) ratio of -0.24, price-to-book of 0.68, price-to-sales of 2.59. Over the past 52 weeks the stock has ranged between $0.57 and $6.70, and currently trades 87.3% below its 52-week high.

On profitability, Bio Green Med Solution, Inc. generates a return on equity (ROE) of -31.60%, return on capital employed of -38.23%, an operating margin of -2.38%, a net profit margin of -118.27%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides